A Focus on Life Sciences
Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that…
Posted by
Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that…
Posted by
PixelOptics’ emPower! eyewear is the world’s first and only electronic focusing eyeglasses—focusing faster than the blink of an eye. The technology is embedded inside the lenses and…
Posted by
The convergence between life sciences and technology cannot be ignored. That’s why at Safeguard Scientifics, we consolidated of our life sciences and technology deal teams.…
Posted by
Ninety percent of migraine sufferers experience nausea, while 60 percent experience vomiting because of their migraine. As a result, today’s most common migraine treatments that…
Posted by
Last week our own Gary J. Kurtzman, MD, Senior Vice President and Managing Director in the Safeguard Life Sciences Group, participated on a panel at…
Posted by
As Peter J. Boni highlighted this morning, despite volatile capital markets and a wobbly economy, Safeguard Scientifics continues to fire on all cylinders by realizing…
Posted by
Safeguard Scientifics will release its financial results for the third quarter ended September 30, 2011 prior to market open on Wednesday, October 26. At 9…
Posted by
It’s the biggest question in our “New Normal” economy—how do you build a successful business during a global recession? Despite the lack of any discernable…
Posted by
This week, we announced details for our Investor Day 2011, scheduled for Tuesday, October, 4 at The Yale Club of New York City. It’s a great…
Posted by